KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
73 hedge funds and large institutions have $226M invested in Kindred Biosciences, Inc. in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $352K
Holders
73
Holding in Top 10
1
Calls
–
Puts
$352K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$9M | |
| 3 | +$4.86M | |
| 4 |
Renaissance Technologies
New York
|
+$2.7M |
| 5 |
BlackRock
New York
|
+$2.36M |
Top Sellers
| 1 | -$2.15M | |
| 2 | -$1.17M | |
| 3 | -$1.09M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$404K |
| 5 |
Citigroup
New York
|
-$339K |